Give the Gift of Hope this Holiday Season! Support PWSA | USA's 2025 Angel Drive. Donate Now

PWSA Blog

Calling Alaska PWS Families

The Alaska Medical Assistance DUR Committee will be meeting on Friday Nov 21, 2025, at 1 pm AK time. Here’s how you can help: The Alaska Medical Assistance DUR Committee needs to hear directly from you – the parents, caregivers, and family members who understand the real-life impact of hyperphagia (excessive hunger) in PWS. One...

Calling Iowa PWS Families for P&T Committee

The Iowa Medicaid Pharmaceutical and Therapeutics (P&T) Committee will be meeting on Thursday, November 20, 2025 at 9:30 am CT both virtually and in person.  Here’s how you can help: The Iowa Medicaid P&T Committee needs to hear directly from you – the parents, caregivers, and family members who understand the real-life impact of hyperphagia...

Calling Iowa PWS Families

The Iowa Medicaid Drug Utilization Review (DUR) Commission will be meeting at 9:30 am CT on November 5, 2025. Here’s how you can help: The Iowa Medicaid DUR Commission needs to hear directly from you – the parents, caregivers, and family members who understand the real-life impact of hyperphagia (excessive hunger) in PWS. One of...

You’re Invited: Webinar on Prader-Willi Syndrome and VYKAT™ XR (diazoxide choline)

Note: This event is hosted by Soleno Therapeutics and shared by PWSA | USA as an educational opportunity for the Prader-Willi syndrome (PWS) community. Families, caregivers, and professionals are invited to join Soleno Therapeutics for an upcoming educational webinar discussing Prader-Willi syndrome and VYKAT™ XR (diazoxide choline), a treatment for individuals 4 years and older...

Soleno Therapeutics to Invest $5 Million in Research Toward a Potential Cure for Prader-Willi Syndrome

PWSA | USA is excited to celebrate a powerful new commitment from Soleno Therapeutics, a company already making history in the Prader-Willi syndrome (PWS) community. Following the FDA approval of VYKAT™ XR (diazoxide choline extended-release tablets), the first-ever treatment for hyperphagia in PWS, Soleno has announced plans to invest up to $5 million in grant...

Calling Indiana PWS Families!

The Indiana Medicaid Drug Utilization Review (DUR) Board Meeting will be meeting October 17, 2025, starting at 10:00 AM EST. Here’s how you can help: The Indiana Medicaid DUR Board needs to hear directly from you – the parents, caregivers, and family members who understand the real-life impact of hyperphagia (excessive hunger) in PWS. One...

HERO Clinical Trial for ARD-101 Now Enrolling Open-Label Extension (OLE)

Earlier this year, Aardvark Therapeutics launched HERO, a global Phase 3 clinical trial investigating ARD-101, an innovative, orally administered treatment designed to help reduce hyperphagia (excessive hunger) and food-seeking behaviors in individuals with Prader-Willi syndrome (PWS). All patients who have completed treatment on the AVK-101-301 study through Week 12/End of Treatment will have the option to join...

Calling Missouri PWS Families!

The Missouri Rare Disease Advisory Council Meeting will be meeting October 8, 2025 from 10:30 AM – 2 PM CDT. Here’s how you can help: The Missouri Rare Disease Advisory Council needs to hear directly from you – the parents, caregivers, and family members who understand the real-life impact of hyperphagia (excessive hunger) in PWS....

Scroll to top